Gautam Patel

Gautam Patel, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Amneal Pharmaceuticals, Inc. and Spectrum Brands Holdings, Inc. In total, 24 filings cover trades dated from 6 May 2021 to 10 August 2026.

On the open market, the record shows 1 purchase worth €186k and 9 sales worth €3.7M. Taken together, the sales exceed the purchases by €3.5M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 6 share grants and 5 option exercises.

The record was last updated on 12 August 2026 with a share grant in Amneal Pharmaceuticals, Inc. The most recent open-market purchase was published on 20 December 2021, 1,763 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.